Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer
Phase 3
Terminated
- Conditions
- Breast Cancer Stage IVBreast Cancer, Stage IIIBBreast Cancer Stage IIIA
- Interventions
- Drug: 1% Glycated ChitosanDrug: Standard of CareDevice: Photothermal LaserDrug: Placebo
- First Posted Date
- 2017-06-28
- Last Posted Date
- 2018-02-23
- Lead Sponsor
- Eske Corporation S.A.C
- Target Recruit Count
- 18
- Registration Number
- NCT03202446
- Locations
- 🇵🇪
Clinica Ricardo Palma, Lima, Peru
🇵🇪Hospital Maria Auxiliadora, Lima, Peru
🇵🇪Hospital Nacional Arzobispo Loayza, Lima, Peru
News
No news found